---
figid: PMC5961736__nihms964503f4
figlink: /pmc/articles/PMC5961736/figure/F4/
number: F4
caption: Overview of PD-1/PD-Ls signaling pathway that acts as effective therapeutic
  targets in lymphoma. Upon binding to its ligands PD-Ls, PD-1 delivers co-inhibitory
  signals, negatively regulating T-cell function to maintain immune balance. In the
  cases of tumor, overexpressed PD-Ls activate PD-1 signaling, leading to exhaustion
  of effector T cell after interaction of PD-1 and PD-Ls. Targeting PD-1 and/or PD-L1
  are the current focus of immunotherapy and clinical management in several solid
  tumor and hematologic malignancies. APC, antigen presenting cell; PD-1, programmed
  death-1; PD-L, programmed death-ligand; MHCII, major histocompatibility complex,
  class II; TCR, T-cell receptor; SHP, Src homology region 2 domain-containing phosphatase;
  ZAP70, zeta chain of T cell receptor associated protein kinase 70; PI3K, phosphoinositide-3-kinase;
  AKT, v-akt murine thymoma viral oncogene homolog1; ERK, extracellular signal-regulated
  kinase; FOXO-1, forkhead box 1; mTOR, mechanistic target of Rapamycin; NFAT, nuclear
  factor of activated T cells; NF-kB, nuclear factor-kappa B.
pmcid: PMC5961736
papertitle: Oncogenic Signaling Pathways and Pathway-Based Therapeutic Biomarkers
  in Lymphoid Malignancies.
reftext: Ruifang Sun, et al. Crit Rev Oncog. ;22(5-6):527-557.
pmc_ranked_result_index: '138871'
pathway_score: 0.9603884
filename: nihms964503f4.jpg
figtitle: PD-1/PD-Ls signaling pathway that acts as effective therapeutic targets
  in lymphoma
year: ''
organisms:
- Homo sapiens
ndex: 4d7db003-dede-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5961736__nihms964503f4.html
  '@type': Dataset
  description: Overview of PD-1/PD-Ls signaling pathway that acts as effective therapeutic
    targets in lymphoma. Upon binding to its ligands PD-Ls, PD-1 delivers co-inhibitory
    signals, negatively regulating T-cell function to maintain immune balance. In
    the cases of tumor, overexpressed PD-Ls activate PD-1 signaling, leading to exhaustion
    of effector T cell after interaction of PD-1 and PD-Ls. Targeting PD-1 and/or
    PD-L1 are the current focus of immunotherapy and clinical management in several
    solid tumor and hematologic malignancies. APC, antigen presenting cell; PD-1,
    programmed death-1; PD-L, programmed death-ligand; MHCII, major histocompatibility
    complex, class II; TCR, T-cell receptor; SHP, Src homology region 2 domain-containing
    phosphatase; ZAP70, zeta chain of T cell receptor associated protein kinase 70;
    PI3K, phosphoinositide-3-kinase; AKT, v-akt murine thymoma viral oncogene homolog1;
    ERK, extracellular signal-regulated kinase; FOXO-1, forkhead box 1; mTOR, mechanistic
    target of Rapamycin; NFAT, nuclear factor of activated T cells; NF-kB, nuclear
    factor-kappa B.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - MAPK3
  - AKT1
  - AKT3
  - PRKCZ
  - FOXO1
  - PRKCA
  - PTPN11
  - TRA
  - PRKD3
  - PDCD1
  - CD274
  - PDCD1LG2
  - TRB
  - KRAS
  - HRAS
  - NRAS
  - PRKCQ
  - NFAT5
  - TRD
  - AKT2
  - MTOR
  - APC
  - CD3D
  - CD3E
  - CD3G
  - CD247
  - PRKCB
  - NFATC1
  - NFATC2
  - TRG
  - NFATC4
  - NFKB1
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCD
  - PRKCE
  - ZAP70
  - NFATC3
  - Cancer
genes:
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: FOXO-1,
  symbol: FOXO1
  source: hgnc_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: SHP-2
  symbol: SHP-2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: PD-L2
  symbol: PD-L2
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1LG2
  entrez: '80380'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: NFAT,
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFAT5
  entrez: '10725'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: mTOR,
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: CD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD3D
  entrez: '915'
- word: CD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD3E
  entrez: '916'
- word: CD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD3G
  entrez: '917'
- word: CD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD247
  entrez: '919'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: NFAT,
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC1
  entrez: '4772'
- word: NFAT,
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC2
  entrez: '4773'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: NFAT,
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC4
  entrez: '4776'
- word: NF-kB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: ZAP70
  symbol: ZAP70
  source: hgnc_symbol
  hgnc_symbol: ZAP70
  entrez: '7535'
- word: NFAT,
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC3
  entrez: '4775'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC5961736__F4
redirect_from: /figures/PMC5961736__F4
figtype: Figure
---
